Terapie e Vaccini SARS-Cov-2 | Vaccini

In rosso le review, in verde gli RCT.

•  JAMA, 16 ottobre 2020 | “Answering Key Questions About COVID-19 Vaccines”
•  JAMA, 16 ottobre 2020| “Postlicensure Evaluation of COVID-19 Vaccines”
•  New England Journal of Medicine, 14 ottobre 2020 | “Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates”
• New England Journal of Medicine, 29 settembre 2020 | “Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults”
• Nature, 23 settembre 2020 | “SARS-CoV-2 vaccines in development”
•  The Lancet, 4 settembre 2020
  Link: Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia
• The Lancet, 4 settembre 2020 (editoriale)
  Link: COVID-19 vaccines: early success and remaining challenges
• JAMA , 3 settembre 2020
  Link: COVID-19 and mRNA Vaccines—First Large Test for a New Approach
• New England Journal of Medicine, 28 luglio 2020
  Link: Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates
• The Lancet, 20 luglio 2020
  Link: Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
• The Lancet, 20 luglio 2020
  Link: Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial
• The Lancet, 20 luglio 2020 (editoriale)
  Link: Encouraging results from phase 1/2 COVID-19 vaccine trials
• New England Journal of Medicine, 14 luglio 2020
  Link: An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
• New England Journal of Medicine, 14 luglio 2020 (editoriale)
  Link: The Covid-19 Vaccine-Development Multiverse
• JAMA , 6 luglio 2020
  Link: The Development of COVID-19 VaccinesSafeguards Needed
• New England Journal of Medicine , 1 luglio 2020
  Link: Accelerating Development of SARS-CoV-2 Vaccines — The Role for Controlled Human Infection Models
• Vaccini: a che punto siamo
  Link: The New York Times – Coronavirus Vaccine Tracker
• New England Journal of Medicine, 18 giugno 2020
  Link: Amplifying RNA Vaccine Development